Zoetis Stock News

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy

In the latest trading session, Zoetis (ZTS) closed at $145.54, marking a -0.66% move from the previous day.

Short-term bonds currently yield more than stocks, indicating a shift in the investment environment. Investors should focus on companies with healthy balance sheets, pricing power, and that are tradin

Zoetis Inc. has seen a significant decline in its stock price, dropping more than 24% since January. The decline is partly due to market weakness and the ongoing growth to value rotation, as well as h

Zoetis Inc (NYSE:ZTS, ETR:ZOE) shares took a hit Friday after a Wall Street Journal report that suggested the company's arthritis shots may have sickened dogs and cats. The arthritis shots, Librela an

An article in The Wall Street Journal highlights the scrutiny over the company's arthritis treatments for pets.

Zoetis Inc.'s stock ZTS, -7.77% tumbled 7% Friday to lead S&P 500 decliners, after a Wall Street Journal report that the company's arthritis shots Librela and Solensia may have sickened pet cats and d

The latest trading day saw Zoetis (ZTS) settling at $165.69, representing a -0.1% change from its previous close.

The SPDR S&P 500 ETF Trust had a 3.27% return in March, outperforming Vanguard's Dividend Appreciation Index Fund ETF Shares. The top 15 dividend growth stocks for April 2024 offer an average dividend

Lululemon offered weaker-than-expected guidance in its fourth-quarter earnings report. Southwest cut its guidance in response to the crisis at Boeing.

PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, May 2, 2024. Chief Executive Officer Kristin Pec

It is possible for retail investors to consistently beat the market by owning above-average blue chip dividend growth stocks. Hard work, research, and staying rational are key factors in outperforming

Zoetis Inc. has shown unique compounding results since spinning off from Pfizer, with double-digit EPS and dividend growth CAGRs since inception. The loneliness epidemic is driving demand for companio

The SPDR S&P 500 ETF Trust had a 5.22% return in February, outperforming Vanguard's Dividend Appreciation Index Fund ETF Shares.

Zoetis: Buy This High-Quality Dividend Growth Beast On Weakness